Apie Therapeutics, Inc.

Biotechnology company · Cary, North Carolina, United States

Apie Therapeutics, Inc. is a biotechnology company headquartered in Cary, North Carolina, United States. Its earliest recorded incorporation is in 2020. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $452,422 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $100,000 sold in a notice filed in 2020.

www.apie-therapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Apie Therapeutics at a glance

Typebiotechnology company
HeadquartersCary, North Carolina, United States
Earliest incorporation on record2020
Employees (self-reported, 2023)2
SEC CIK1826212

What does Apie Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $452,422 in total (2023). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $100,000 sold (2020).

Frequently asked questions about Apie Therapeutics

Where is Apie Therapeutics headquartered?

Apie Therapeutics, Inc. is headquartered in Cary, North Carolina, United States.

What does Apie Therapeutics do?

Apie Therapeutics, Inc. is a biotechnology company.

When was Apie Therapeutics founded?

The earliest incorporation on record for Apie Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences